Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Debt to Equity (2016 - 2025)

Abeona Therapeutics has reported Debt to Equity over the past 11 years, most recently at $0.13 for Q4 2025.

  • Quarterly results put Debt to Equity at $0.13 for Q4 2025, down 70.78% from a year ago — trailing twelve months through Dec 2025 was $0.13 (down 70.78% YoY), and the annual figure for FY2025 was $0.13, down 70.78%.
  • Debt to Equity for Q4 2025 was $0.13 at Abeona Therapeutics, up from $0.12 in the prior quarter.
  • Over the last five years, Debt to Equity for ABEO hit a ceiling of $0.72 in Q3 2022 and a floor of -$2.04 in Q1 2024.
  • Median Debt to Equity over the past 4 years was $0.22 (2021), compared with a mean of $0.15.
  • Biggest five-year swings in Debt to Equity: plummeted 91.19% in 2021 and later skyrocketed 2911.23% in 2022.
  • Abeona Therapeutics' Debt to Equity stood at $0.2 in 2021, then fell by 21.79% to $0.16 in 2022, then skyrocketed by 176.85% to $0.43 in 2024, then plummeted by 70.78% to $0.13 in 2025.
  • The last three reported values for Debt to Equity were $0.13 (Q4 2025), $0.12 (Q3 2025), and $0.12 (Q2 2025) per Business Quant data.